Editorial: Antithrombotic Treatment in Transcatheter Structural Cardiac Interventions and After Cardiac Device Implantation
نویسندگان
چکیده
منابع مشابه
Cardiac dysrhythmias after transcatheter closure of ASD with Amplatzer device.
Transcatheter closure of atrial septal defect (ASD) has been used as an alternative to open heart surgery. Although transcatheter closure of ASD with the Amplatzer septal occluder is a safe and feasible method in pediatric patients, there is little published data on arrhythmia analysis following transcatheter device closure of secundum ASD. We evaluated cardiac dysrhythmias with 24-hour ambulat...
متن کاملAdvances in cardiac rehabilitation: cardiac rehabilitation after transcatheter aortic valve implantation.
Due to the demographic change and an aging population, the prevalence of the most frequent valve disease, aortic stenosis (AS), is still rising.
متن کاملAntithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI).
Transcatheter aortic valve implantation (TAVI) is an established treatment option for symptomatic patients with severe aortic valvular disease who are not suitable for conventional surgical aortic valve replacement. Despite improving experience and techniques, ischaemic and bleeding complications after TAVI remain prevalent and impair survival in this generally old and comorbid-rich population....
متن کاملEditorial TREATMENT OF SUDDEN CARDIAC DEATH SURVIVORS: DRUGS VERSUS DEVICE
Patients who survive an episode of sustained ventricular trachycardia (VT) or out-of-hospital ventricular fibrillation (VF) are known to have a high recurrence rate of 10% to 20% at 2 years.' Until the early 1990s, the preferred therapy for this high-risk population remained unclear. A variety of therapies have been proposed, including serial drug testing guided by Holter monitor or eletrophysi...
متن کاملCardiac device implantation in Fabry disease
The incidence and predictive factors of arrhythmias and/or conduction abnormalities (ACAs) requiring cardiac device (CD) implantation are poorly characterized in Fabry disease (FD). The aim of our retrospective study was to determine the prevalence, incidence, and factors associated with ACA requiring CD implantation in a monocentric cohort of patients with confirmed FD who were followed up in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Cardiovascular Medicine
سال: 2020
ISSN: 2297-055X
DOI: 10.3389/fcvm.2020.616638